From:  Using pharmacy electronic communication to identify patients at high risk of asthma exacerbation: a community-based study in Australia and New Zealand

 Patients who visited a GP/hospital for bad asthma and the frequency of OCS used, and SABA purchased for their asthma.

In the last 12 monthsGP/Hospital visits for bad asthmap-value
Yes
(n = 141)
No
(n = 112)
Number of OCS used for asthma
    1–272 (51.1%)77 (68.8%)< 0.05
    ≥ 369 (48.9%)35 (31.2%)
Number of SABAs purchased
    0–230 (21.3%)47 (42.0%)< 0.01
    ≥ 3111 (78.7%)65 (58.0%)